MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...
French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...
Even the largest and most complex teams can work together effectively if the right conditions are in place. by Lynda Gratton and Tamara J. Erickson When tackling a major initiative like an acquisition ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
SPG Simon Property Group, Inc.
Abstract: This paper presents a pipelined SAR ADC with a two-stage closed-loop residue amplifier (RA). The proposed RA incorporates a floating gm-ratio-based amplifier (FGA) as the first stage and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results